Bright Light Therapy for Lung Cancer
(BLT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether bright light therapy can improve sleep and potentially slow aging in lung cancer patients, based on specific biological markers. Participants will either receive bright light exposure or continue with their usual light for four weeks. Lung cancer patients who have completed primary treatment and experience sleep problems may find this trial suitable. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance sleep and overall well-being for lung cancer patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you take prescribed sedative hypnotics, antipsychotics, or photosensitizing medications.
What prior data suggests that bright light therapy is safe for lung cancer patients?
Studies have shown that bright light therapy is generally safe and easy to manage. Research suggests it is a simple, low-cost treatment with few side effects. For cancer patients, including those with lung cancer, several reviews consider light therapy safe. Evidence of serious side effects is limited, making harm unlikely. Overall, participants in previous studies handled bright light therapy well, with no major safety concerns reported.12345
Why are researchers excited about this trial?
Bright Light Therapy is unique because it offers a non-invasive and drug-free approach to managing lung cancer symptoms. Unlike standard treatments like chemotherapy or radiation, which often come with significant side effects, Bright Light Therapy uses a light visor to deliver 30 minutes of bright light exposure daily. Researchers are excited about this treatment because it could improve patients' quality of life by potentially enhancing mood and energy levels without the usual downsides of traditional lung cancer therapies.
What evidence suggests that bright light therapy is effective for improving sleep and slowing biological aging in lung cancer patients?
Research has shown that bright light therapy, which participants in this trial may receive, can greatly improve sleep quality in cancer patients. One study found that it lowered the Pittsburgh Sleep Quality Index (PSQI) score, indicating better sleep. Another study demonstrated that bright light therapy helps individuals treated for cancer sleep more soundly. It might also alleviate cancer-related fatigue, a common issue for patients. Overall, bright light therapy appears to be a safe and effective method to help lung cancer patients sleep better and feel less tired.12467
Are You a Good Fit for This Trial?
This trial is for lung cancer patients experiencing sleep disturbances. Participants will use bright light therapy daily for 4 weeks and must be willing to have their blood drawn twice, complete surveys on sleep, fatigue, and stress, as well as keep a daily sleep log.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive bright light exposure or usual light exposure every day for 4 weeks
Follow-up
Participants are monitored for changes in sleep patterns, biological age, fatigue, and stress levels
What Are the Treatments Tested in This Trial?
Interventions
- Bright Light Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Henry Ford Health System
Lead Sponsor
Michigan State University
Collaborator